Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption and liver-related outcomes: A systematic review and meta-analysis
- 15 August 2025
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 275, 112840
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Association of Glucagon-Like Peptide-1 Receptor Agonist with Progression to Liver Cirrhosis and Alcohol-Related Admissions in Patients with Alcohol Use Disorder and Diabetes: A Retrospective Cohort StudyDrugs, 2025
- Once-Weekly Semaglutide in Adults With Alcohol Use DisorderJAMA Psychiatry, 2025
- Repurposing Semaglutide and Liraglutide for Alcohol Use DisorderJAMA Psychiatry, 2025
- Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver diseaseJournal of Hepatology, 2024
- Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic revieweClinicalMedicine, 2024
- GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative revieweClinicalMedicine, 2024
- Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeysPsychopharmacology, 2024
- Pharmacotherapy for Alcohol Use DisorderJAMA, 2023
- Semaglutide reduces alcohol intake and relapse-like drinking in male and female ratsEBioMedicine, 2023
- Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeysPsychopharmacology, 2018